Search

Author/Creator Kalapanida, Despoina

1. Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma. Issue 8 (2nd August 2016)

Authors:
Zagouri, Flora; Roussou, Maria; Kastritis, Efstathios; Gavriatopoulou, Maria; Eleutherakis-Papaiakovou, Evangelos; Kanellias, Nikolaos; Kalapanida, Despoina; Christoulas, Dimitrios; Migkou, Magdalini; Terpos, Evangelos; Dimopoulos, Meletios A
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 8(2016:Aug.)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma. (13th November 2015)

Authors:
Bagratuni, Tina; Terpos, Evangelos; Eleutherakis‐Papaiakovou, Evangelos; Kalapanida, Despoina; Gavriatopoulou, Maria; Migkou, Magdalini; Liacos, Christine‐Ivy; Tasidou, Anna; Matsouka, Charis; Mparmparousi, Despoina; Dimopoulos, Meletios A.; Kastritis, Efstathios
Journal:
British journal of haematology
Issue:
Volume 172:Number 1(2016)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search